FMS vs. NTRA, OPCH, PACS, HIMS, GH, AGL, PRVA, FTRE, LFST, and NHC
Should you be buying Fresenius Medical Care stock or one of its competitors? The main competitors of Fresenius Medical Care include Natera (NTRA), Option Care Health (OPCH), PACS Group (PACS), Hims & Hers Health (HIMS), Guardant Health (GH), agilon health (AGL), Privia Health Group (PRVA), Fortrea (FTRE), LifeStance Health Group (LFST), and National HealthCare (NHC). These companies are all part of the "healthcare" industry.
Natera (NASDAQ:NTRA) and Fresenius Medical Care (NYSE:FMS) are both large-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, dividends, community ranking, profitability, analyst recommendations, valuation, risk, institutional ownership and media sentiment.
Natera received 47 more outperform votes than Fresenius Medical Care when rated by MarketBeat users. Likewise, 68.56% of users gave Natera an outperform vote while only 54.29% of users gave Fresenius Medical Care an outperform vote.
In the previous week, Natera had 18 more articles in the media than Fresenius Medical Care. MarketBeat recorded 22 mentions for Natera and 4 mentions for Fresenius Medical Care. Natera's average media sentiment score of 0.60 beat Fresenius Medical Care's score of 0.42 indicating that Fresenius Medical Care is being referred to more favorably in the news media.
99.9% of Natera shares are owned by institutional investors. Comparatively, 8.3% of Fresenius Medical Care shares are owned by institutional investors. 7.6% of Natera shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.
Natera has a beta of 1.48, meaning that its share price is 48% more volatile than the S&P 500. Comparatively, Fresenius Medical Care has a beta of 0.9, meaning that its share price is 10% less volatile than the S&P 500.
Fresenius Medical Care has a net margin of 2.48% compared to Fresenius Medical Care's net margin of -30.24%. Natera's return on equity of 5.29% beat Fresenius Medical Care's return on equity.
Fresenius Medical Care has higher revenue and earnings than Natera. Natera is trading at a lower price-to-earnings ratio than Fresenius Medical Care, indicating that it is currently the more affordable of the two stocks.
Natera currently has a consensus price target of $101.19, indicating a potential downside of 1.44%. Fresenius Medical Care has a consensus price target of $24.00, indicating a potential upside of 18.23%. Given Natera's higher probable upside, analysts plainly believe Fresenius Medical Care is more favorable than Natera.
Summary
Natera and Fresenius Medical Care tied by winning 9 of the 18 factors compared between the two stocks.
Get Fresenius Medical Care News Delivered to You Automatically
Sign up to receive the latest news and ratings for FMS and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding FMS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Fresenius Medical Care Competitors List
Related Companies and Tools
